BioSpace News Archive

Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will present and participate in a panel discussion at Jefferies Inaugural Radiopharma Innovation Summit in New York City on Monday, April 3, 2023.

BioSig Technologies, Inc. today announced the appointment of new Advisory Board member Edwin Wang.

LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today reported financial results for the fourth quarter and year ended December 31, 2022.

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), the parent company of BioKey and affiliate of BioStrand, announced today that the EPO has issued a “Decision to Grant” for BioKey’s patent application covering the company’s HYFT® Technology used to organize and analyze biological sequence information.

Anixa Biosciences, Inc. today announced a presentation on results of its Phase 1a breast cancer vaccine trial on April 17, 2023, at the 2023 American Association for Cancer Research (AACR) Annual Meeting.

Salarius Pharmaceuticals, Inc. today reported financial results for the three and 12 months ended December 31, 2022 and provided a business update.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it will report its financial results for the full year December 31, 2022 after market close on Friday, March 31, 2023.

Barrow Neurological Institute at Phoenix Children’s, one of the largest pediatric neuroscience programs in the country, announced the appointment of Neil Friedman, MBChB as director.

Oncternal Therapeutics, Inc. today announced the approval of an inducement award to one new employee, Erik S. Nelson, who joined Oncternal as Head of IT.

Passage Bio, Inc. today announced that William Chou, M.D., chief executive officer, will participate in a fireside chat at the upcoming Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days on Monday, April 3, 2023 at 3:55 p.m. ET in New York, NY.